Rohit Malik
About Rohit Malik
Rohit Malik is the Associate Director at Bristol Myers Squibb in Redwood City, California, with extensive experience in oncology research and genomics.
Title: Associate Director
Rohit Malik currently holds the position of Associate Director at Bristol Myers Squibb in Redwood City, California. His role involves leading initiatives and working groups within the organization, focusing on innovative research and translational studies within the biopharmaceutical sector.
Professional Background
Rohit Malik has an extensive background in scientific research and leadership. He has held multiple roles at Bristol Myers Squibb, including Principal Scientist, Senior Research Investigator II in Immuno-Oncology Resistance Biology, and Research Investigator II in Tumor Genetics and Signaling. Before joining Bristol Myers Squibb, he worked at the Michigan Center for Translational Pathology, University of Michigan, as both a Research Investigator and Research Fellow. He also served as a Graduate Student at Loyola University Chicago Stritch School of Medicine and as a DNA analyst at the Central Forensic Science Laboratory.
Education and Expertise
Rohit Malik completed a PhD in Molecular Biology at Loyola University Chicago Stritch School of Medicine. He also holds an MSc in Microbiology and a BS in Microbiology from Panjab University. Additionally, he has a Post Graduate Diploma in Bioinformatics from the Bioinformatics Institute of India. His educational background provides a strong foundation for his expertise in high throughput functional genomics, genome-wide CRISPR screening, in-vivo pharmacology studies, and the establishment of in-vivo models to assess tumor microenvironment interactions.
Collaborations and Innovations
Throughout his career, Rohit Malik has initiated and executed multiple academic and industry collaborations. These collaborations are designed to test novel ideas, drive innovation, and support portfolio projects. This includes leveraging high throughput functional genomics and genome-wide CRISPR screening data to identify novel tumor cell-intrinsic targets and forging close partnerships with translational and genomics teams to refine and validate predictive and pharmacodynamic biomarker hypotheses for portfolio projects.
Research and Development Initiatives
In his role at Bristol Myers Squibb, Rohit Malik has led significant research and development initiatives. He has extensive experience in in-vivo pharmacology studies, focusing on pharmacokinetics, pharmacodynamics, and efficacy to support lead optimization efforts. He has also been instrumental in establishing in-vivo models to explore the interaction between tumor cells and their microenvironment, contributing valuable insights to the field of oncology.